 |
| "When a distinguished... scientist states that something is possible, he is almost certainly right. When he states that something is impossible, he is very probably wrong."
|
Steve's own technical expertise lies in cellular and molecular biology, cancer research, drug development, vaccines and immunology, regenerative medicine and stem cells, and infectious diseases. He also has access to a panel of associates for projects requiring expertise in bio-engineering, bio-informatics, chemistry, bio-physics, and clinical and veterinary science.
Steve uniquely offers ongoing review of biotechnology, markets and competition for businesses and investors who need to keep abreast of current developments in certain areas.
For bioscience investors and associations, Steve and his associates provide assessment of emerging bioscience technologies. Services include, but are not limited to:
- technical analysis of emerging biotechnology
- evaluation of competing technologies
- ongoing technical review of a company and its market
- education, training and speaking on bioscience and bioethics topics
The following expert assistance is also available to biotechnology businesses:
- assistance with Small Business Innovation Research (SBIR) and other federal or state grant programs
- advice and assistance on preparing presentations for investors or symposia
- assistance writing papers or other technical material for publication in journals, websites, etc.
- background research for new projects, grants, papers, etc.
- market analysis and evaluation of competition
- ongoing technical review of competition
- education, training and speaking on bioscience and bioethics topics
- medical science liasion for communicating scientific information to area-wide key opinion leaders in order to promote company value and/or technology
